Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s interface/update footer revision label has been advanced from v3.5.2 to v3.5.3, indicating a minor platform release rather than a change to the clinical trial record itself.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedLatest version updates core study details such as Study Status and Contacts/Locations, reflecting current recruitment status and site information.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the history.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated to v3.4.3. The previous v3.4.2 entry is now obsolete.SummaryDifference0.0%

- Check60 days agoChange DetectedThe new version updates the Study Status and Contacts/Locations sections, reflecting the current trial status and site details.SummaryDifference0.0%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.